The treatment of FXS fibroblasts for 7 days with increasing concentrations of 5-aza-dC, ranging from 0.25 μM to 5 μM, showed maximal reactivation of FMR1 mRNA levels at 1 μM 5-aza-dC (Figure S1A). The gene discussed is FMR1; the disease is fragile X syndrome.